The NIH Division of Biologics Standards (DBS) licensed the rubella vaccine for use in June 1969. Explore this selection of items from the NLM Digital Collections to discover how scientists working at the DBS set policy, conducted research, and enforced standards to ensure the safety of vaccines.
“Biologics Standards Division Established; Larson Named Chief,” NIH Record, Bethesda, Maryland, June 27, 1955
Courtesy National Library of Medicine
The NIH Record, an internal publication for NIH staff, celebrated the creation of DBS in 1955. It reported that the new division would increase research staff and improve their capacity to test products, visit factories and production sites, conduct investigations, and collect data on biologics products.